{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:59:04Z","timestamp":1790499544682,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1111\/j.1365-2133.2011.10732.x","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T06:38:58Z","timestamp":1321511938000},"page":"844-852","source":"Crossref","is-referenced-by-count":79,"title":["Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris"],"prefix":"10.1093","volume":"166","author":[{"given":"M.","family":"Behzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"M\u00f6bs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kneisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Eming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.122.2.409","article-title":"Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes","volume":"122","author":"Karpati","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000024364","article-title":"Humoral and cellular autoimmunity in autoimmune bullous skin disorders","volume":"122","author":"Hertl","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB10|cit10","first-page":"689","article-title":"The actual management of pemphigus","volume":"145","author":"Daniel","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB12|cit12","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"1","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2011.10732.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000246938","article-title":"Correlation of subclasses of IgG with disease activity in pemphigus vulgaris","volume":"189","author":"Bhol","year":"1994","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI115968","article-title":"Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic","volume":"90","author":"Amagai","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2230.2000.00624.x","article-title":"Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3","volume":"25","author":"Harman","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/08916930600972040","article-title":"Immunoadsorption in pemphigus","volume":"39","author":"Eming","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","article-title":"Immunoadsorption in dermatology","volume":"302","author":"Schmidt","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000090659","article-title":"Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption","volume":"212","author":"Eming","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000187431","article-title":"Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab","volume":"218","author":"Pfutze","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2230.2006.02220.x","article-title":"Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption","volume":"31","author":"Shimanovich","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1365-2133.2003.05302.x","article-title":"Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus","volume":"148","author":"Schmidt","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2133.2003.05513.x","article-title":"Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber","volume":"149","author":"Luftl","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrrheum.2009.141","article-title":"B-cell-directed therapies for autoimmune disease","volume":"5","author":"Dorner","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus","volume":"153","author":"Arin","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/jid.2008.172","article-title":"Rituximab exerts a dual effect in pemphigus vulgaris","volume":"128","author":"Eming","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000100876","article-title":"Rituximab (anti-CD20 monoclonal antibody) - ultimate or first choice in pemphigus?","volume":"214","author":"Hertl","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.2007.08358.x","article-title":"Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins","volume":"158","author":"Shimanovich","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB34|cit34","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pfutze","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2007.00615.x","article-title":"IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris","volume":"17","author":"Muller","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1610-0387.2007.06342.x","article-title":"Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases","volume":"5","author":"Zillikens","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2133.2003.05580.x","article-title":"Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab","volume":"149","author":"Goebeler","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB38|cit38","first-page":"379","article-title":"Response in patients with pemphigus vulgaris to rituximab therapy. Basis of the biology of B cells","volume":"144","author":"Leuci","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1468-3083.2008.02715.x","article-title":"Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission","volume":"22","author":"Kwon","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Reliability and convergent validity of two outcome instruments for pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10732.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10732.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10732.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T20:13:06Z","timestamp":1713125586000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/4\/844\/6613591"}},"subtitle":["Immunoadsorption and rituximab in pemphigus vulgaris"],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10732.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}